skip to main content
Idioma:
Refinado por: idioma: Russo remover Cancer remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Comparative analysis of the sensitivity of endometrial cancer cells to epidermal growth factor and steroid hormones
Comparative analysis of the sensitivity of endometrial cancer cells to epidermal growth factor and steroid hormones
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparative analysis of the sensitivity of endometrial cancer cells to epidermal growth factor and steroid hormones

Gershtein, Elena S. ; Shatskaya, Valentina A. ; Kostyleva, Olga I. ; Ermilova, Valeriya D. ; Kushlinsky, Nicolai E. ; Krasil'nikov, Mikhail A.

Cancer, 1995-12, Vol.76 (12), p.2524-2529 [Periódico revisado por pares]

New York: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
2
The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: An analysis of 258 patients
The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: An analysis of 258 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: An analysis of 258 patients

KORSHUNOV, Andrey ; GOLANOV, Andrey ; SYCHEVA, Regina ; TIMIRGAZ, Valery

Cancer, 2004-03, Vol.100 (6), p.1230-1237 [Periódico revisado por pares]

New York, NY: Wiley-Liss

Texto completo disponível

Citações Citado por
3
Expanding Nilotinib Access in Clinical Trials (ENACT): An Open-Label, Multicenter Study of Oral Nilotinib in Adult Patients With Imatinib-Resistant or Imatinib-Intolerant Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in the Chronic Phase
Expanding Nilotinib Access in Clinical Trials (ENACT): An Open-Label, Multicenter Study of Oral Nilotinib in Adult Patients With Imatinib-Resistant or Imatinib-Intolerant Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in the Chronic Phase
Material Type:
Artigo 		Adicionar ao Meu Espaço

Expanding Nilotinib Access in Clinical Trials (ENACT): An Open-Label, Multicenter Study of Oral Nilotinib in Adult Patients With Imatinib-Resistant or Imatinib-Intolerant Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in the Chronic Phase

NICOLINI, Franck E ; TURKINA, Anna ; SHEN, Zhi-Xiang ; GALLAGHER, Neil ; JOOTAR, Saengsuree ; POWELL, Bayard L ; DE SOUZA, Carmino ; MING ZHENG ; SZCZUDLO, Tomasz ; LE COUTRE, Philipp

Cancer, 2012, Vol.118 (1), p.118-126 [Periódico revisado por pares]

Hoboken, NJ: Wiley-Blackwell

Texto completo disponível

Citações Citado por
4
Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor‐positive breast cancer
Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor‐positive breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor‐positive breast cancer

Semiglazov, Vladimir F. ; Semiglazov, Vladislav V. ; Dashyan, Garik A. ; Ziltsova, Elena K. ; Ivanov, Vadim G. ; Bozhok, Alla A. ; Melnikova, Olga A. ; Paltuev, Ruslan M. ; Kletzel, Alexander ; Berstein, Lev M.

Cancer, 2007-07, Vol.110 (2), p.244-254 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
5
Examination of the proliferative activity of tumor cells in human lymphoid neoplasms using a morphometric approach
Examination of the proliferative activity of tumor cells in human lymphoid neoplasms using a morphometric approach
Material Type:
Artigo 		Adicionar ao Meu Espaço

Examination of the proliferative activity of tumor cells in human lymphoid neoplasms using a morphometric approach

Sheval, Eugene V. ; Churakova, Janna V. ; Dudnik, Oksana A. ; Vorobjev, Ivan A.

Cancer, 2004-06, Vol.102 (3), p.174-185 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.